Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
نویسندگان
چکیده
There has been increasing recognition that the second-generation antipsychotic drugs can produce extrapyramidal side effects. This case reports the development of severe akathisia in a patient being treated with ziprasidone for bipolar depression. The case illustrates that this symptom can be easily mistaken for worsening agitated depression. Akathisia may produce considerable distress and elevate suicide risk. Such symptoms may persist for weeks and be refractory to discontinuation of the offending agent or to pharmacological interventions commonly used to mitigate this reaction.
منابع مشابه
Treatment of Akathisia by Propranolol
A condition of motor restlessness ranging from a feeling of inner disquiet to inability to sit or lie quietly or to sleep.Called also acathisia, akithisia, and Kathisiophobia (1). The term ''Akathisia" was created by Haskovec in 1901. Haase first applied the term (1955) to the inability to sit still and to the other irritative hyperkinetic symptoms that are sometimes seen as a complication of ...
متن کاملSymptoms of agitated depression and/or akathisia.
Akathisia is a syndrome characterized by the unpleasant sensation of "inner" restlessness that manifests itself in the inability of sitting still or not moving. Many types of medicaments can cause akathisia as an adverse event of their use and they include: antipsychotics, antidepressants, antiemetics, antihistamines, and psychoactive substances. We will present the case of a 50 year old patien...
متن کاملUpdate on schizophrenia and bipolar disorder: focus on cariprazine
Schizophrenia and bipolar disorder are severe psychiatric disorders that are frequently associated with persistent symptoms and significant dysfunction. While there are a multitude of psychopharmacologic agents are available for treatment of these illnesses, suboptimal response and significant adverse consequences limit their utility. Cariprazine is a new, novel antipsychotic medication with do...
متن کاملZiprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.
OBJECTIVE The authors sought to test the efficacy of adjunctive ziprasidone in adults with nonpsychotic unipolar major depression experiencing persistent symptoms after 8 weeks of open-label treatment with escitalopram. METHOD This was an 8-week, randomized, double-blind, parallel-group, placebo-controlled trial conducted at three academic medical centers. Participants were 139 outpatients wi...
متن کاملZiprasidone in the treatment of mania in bipolar disorder
Ziprasidone is an atypical antipsychotic with a unique receptor-binding profile. Currently, ziprasidone is approved by the US Food and Drug Administration for the acute treatment of psychosis in schizophrenia and mania in bipolar disorder. When compared to certain other atypical antipsychotics, ziprasidone appears to have a relatively benign side effect profile, especially as regards metabolic ...
متن کامل